Home  >  News
you can get e-magazine links on WhatsApp.Click here
Pioma_Lactic
News
  Relief Therapeutics Holding SA (Relief) announced that it has signed a collaboration agreement with InveniAI LLC (InveniAI), a US based company that has pioneered the application of artificial intelligence and,   November 25, 2021
  Zenas BioPharma buys exclusive worldwide rights to obexelimab from Xencor,   November 23, 2021
  Boehringer Ingelheim launches additional heart failure indication for Jardiance in India,   November 22, 2021
  Roche’s Gavreto gets European conditional marketing authorisation to treat adults with RET fusion-positive advanced NSCLC,   November 22, 2021
  Pfizer’s Xeljanz receives European marketing authorization to treat active ankylosing spondylitis,   November 20, 2021
  EMA begins evaluation of Novavax’s Covid-19 vaccine, Nuvaxovid application for conditional marketing authorization,   November 19, 2021
  Zydus Cadila receives US FDA approval to market nelarabine injection,   November 18, 2021
  Biogen’ Vumerity gets European marketing authorization to treat relapsing-remitting multiple sclerosis,   November 18, 2021
  Cellenion inks co-marketing agreement with Thermo Fisher Scientific to advance single cell proteomics analyses,   November 17, 2021
  EMA grants marketing authorization to Celltrion’s regdanvimab to treat Covid-19,   November 16, 2021
  Theramex inks pact with Se-cure Pharmaceuticals to market non-hormonal therapy, Femarelle to treat menopause symptoms,   November 16, 2021
  EMA committee recommends conditional marketing authorization for Amgen’s Lumykras to treat KRAS G12C-mutated advanced NSCLC,   November 15, 2021
  Zydus receives US FDA approval to market eluxadoline tablets,   November 15, 2021
  EMA’s human medicines committee recommends marketing authorisation for Ronapreve & Regkirona for Covid-19,   November 15, 2021
  UK regulators ask eleven retailers to recall cold and flu medicine due to labelling error,   November 13, 2021
  Sun Pharma to introduce MSD and Ridgeback’s molnupiravir under brand name Molxvir in India,   November 12, 2021
  Biohaven, Pfizer ink collaboration to commercialize rimegepant in markets outside US,   November 11, 2021
  Zydus Cadila receives US FDA approval to market glycopyrrolate injection,   November 10, 2021
  Beximco Pharma launches generic molnupiravir, an oral antiviral drug to treat Covid-19,   November 10, 2021
  Endo inks pact with Premier to supply Vasostrict vials, essential for Covid-19 care,   November 09, 2021

 Back
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |